Becton Dickinson and Co had two patents in 3D printing during Q2 2024. Becton Dickinson and Co has developed absorbable implants for breast tissue regeneration, providing volume and shape through a reinforced matrix filled with degradable hydrogels. These implants prevent fluid accumulation, promote tissue ingrowth, and are absorbed once tissue ingrowth is complete. Additionally, the company has developed methods for 3D printing objects using poly-4-hydroxybutyrate (P4HB) and copolymers, overcoming feeding and heat creep issues to create objects through various printing techniques. GlobalData’s report on Becton Dickinson and Co gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Becton Dickinson and Co had no grants in 3D printing as a theme in Q2 2024.
Recent Patents
Application: Multi-component breast implant (Patent ID: US20240197466A1)
The patent filed by Becton Dickinson and Co. describes absorbable breast implants that can be used to create volume and shape in the breast of a patient with regenerated tissue. These implants are transient and comprise a reinforced matrix with a load-bearing macroporous network filled with degradable hydrogels or water-soluble polymers that degrade progressively, directing tissue ingrowth. The implants are particularly suitable for plastic surgery procedures, providing an alternative to permanent breast implants.
The claims associated with the patent detail the composition and structure of the breast implants, including the use of different hydrogels and water-soluble polymers, the properties of the load-bearing macroporous network, the shapes of the implants, the presence of anchors or fasteners, and the materials used for manufacturing. The method of manufacturing the implants involves forming a macroporous network of filaments through 3D printing and loading hydrogels or polymers into the network. The method of implanting the implants in a breast includes making incisions, positioning the implant, securing it to nearby tissue, and closing the incisions. Additional features such as coating with autologous fat, injecting various substances, and inserting tissue masses are also described.
To know more about GlobalData’s detailed insights on Becton Dickinson and Co, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.